Furthermore, we have suggested nuclear NHERF1 as a potential new biomarker of advanced CRC, demonstrating an overexpression of nuclear NHERF1 in no longer polarized epithelial cells, converted to a mesenchymal phenotype in hypoxic colonic areas [20]. This evidence concerns the gene NHERF1 and colorectal carcinoma.